Stockreport

LENZ Therapeutics, Inc. (LENZ) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]

LENZ Therapeutics, Inc.  (LENZ) 
PDF This compares to a loss of $0.46 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -28 [Read more]